Homopeptide's most recent public dispatch post on its marketplace subforum dates to 2026-06-05, a 29-day interval that follows a prior window carrying three dispatch threads. The two dispatch posts counted in the current rolling window both predate the 29-day gap, leaving no fresh dispatch cadence since early June. The subforum logged 131 posts in the current window against 171 in the prior, a decline of 23.4%.
The post-type mix shows the subforum still moving, if lightly: 17 discussion posts, one promo, two dispatch posts, and one announcement across the window. The vendor's own account appears sparingly, with a community member posting twice across two threads and drawing zero reactions. Top community voices logged similarly low engagement — a community member Michelle King at three posts, zero reactions across three threads, and a community member Wang MKM at two posts, zero reactions.
Participation contracted alongside the dispatch gap. The most recent seven-day slice held a 6.6-post daily average across 46 posts, and that same slice drew 18 authors, down 38% against the prior window — a distinct sub-window figure separate from the 131-post full-window count.
The reading here is bounded. A dispatch-post absence measures public-thread behavior, not fulfillment health — most peptide transactions clear via DM or vendor-direct channels, so the lack of buyer-posted confirmations is the default state rather than an anomaly. What the record does establish is a behavior change: a vendor that carried three dispatch threads in the prior window has posted none since 2026-06-05, against falling discussion volume and a shrinking author base. That combination reads as reduced public cadence, not a documented fulfillment problem.